201 related articles for article (PubMed ID: 19733211)
1. Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients.
Saito Y; Hamakubo T; Yoshida Y; Ogawa Y; Hara Y; Fujimura H; Imai Y; Iwanari H; Mochizuki Y; Shichiri M; Nishio K; Kinumi T; Noguchi N; Kodama T; Niki E
Neurosci Lett; 2009 Nov; 465(1):1-5. PubMed ID: 19733211
[TBL] [Abstract][Full Text] [Related]
2. Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals.
Akazawa YO; Saito Y; Hamakubo T; Masuo Y; Yoshida Y; Nishio K; Shichiri M; Miyasaka T; Iwanari H; Mochizuki Y; Kodama T; Noguchi N; Niki E
Neurosci Lett; 2010 Oct; 483(3):201-5. PubMed ID: 20708070
[TBL] [Abstract][Full Text] [Related]
3. Establishment of specific antibodies that recognize C106-oxidized DJ-1.
Ooe H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Aug; 404(1-2):166-9. PubMed ID: 16781058
[TBL] [Abstract][Full Text] [Related]
4. Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients.
Saito Y; Akazawa-Ogawa Y; Matsumura A; Saigoh K; Itoh S; Sutou K; Kobayashi M; Mita Y; Shichiri M; Hisahara S; Hara Y; Fujimura H; Takamatsu H; Hagihara Y; Yoshida Y; Hamakubo T; Kusunoki S; Shimohama S; Noguchi N
Sci Rep; 2016 Jul; 6():30793. PubMed ID: 27470541
[TBL] [Abstract][Full Text] [Related]
5. Secretion of DJ-1 into the serum of patients with Parkinson's disease.
Maita C; Tsuji S; Yabe I; Hamada S; Ogata A; Maita H; Iguchi-Ariga SM; Sasaki H; Ariga H
Neurosci Lett; 2008 Jan; 431(1):86-9. PubMed ID: 18162323
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease.
Waragai M; Nakai M; Wei J; Fujita M; Mizuno H; Ho G; Masliah E; Akatsu H; Yokochi F; Hashimoto M
Neurosci Lett; 2007 Sep; 425(1):18-22. PubMed ID: 17720313
[TBL] [Abstract][Full Text] [Related]
7. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
[TBL] [Abstract][Full Text] [Related]
8. Specific cleavage of DJ-1 under an oxidative condition.
Ooe H; Maita C; Maita H; Iguchi-Ariga SM; Ariga H
Neurosci Lett; 2006 Oct; 406(3):165-8. PubMed ID: 16935423
[TBL] [Abstract][Full Text] [Related]
9. [The significance of oxidized DJ-1 protein (oxDJ-1) as a biomarker for Parkinson's disease].
Ogawa I; Saito Y; Saigoh K; Hosoi Y; Mitsui Y; Noguchi N; Kusunoki S
Brain Nerve; 2014 Apr; 66(4):471-7. PubMed ID: 24748095
[TBL] [Abstract][Full Text] [Related]
10. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases.
Choi J; Sullards MC; Olzmann JA; Rees HD; Weintraub ST; Bostwick DE; Gearing M; Levey AI; Chin LS; Li L
J Biol Chem; 2006 Apr; 281(16):10816-24. PubMed ID: 16517609
[TBL] [Abstract][Full Text] [Related]
11. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
[TBL] [Abstract][Full Text] [Related]
12. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Parkinson's disease and the level of oxidized DJ-1 protein.
Yamagishi Y; Saigoh K; Saito Y; Ogawa I; Mitsui Y; Hamada Y; Samukawa M; Suzuki H; Kuwahara M; Hirano M; Noguchi N; Kusunoki S
Neurosci Res; 2018 Mar; 128():58-62. PubMed ID: 28705587
[TBL] [Abstract][Full Text] [Related]
14. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
[TBL] [Abstract][Full Text] [Related]
15. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats.
Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H
J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560
[TBL] [Abstract][Full Text] [Related]
16. Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment.
Alberio T; Colapinto M; Natale M; Ravizza R; Gariboldi MB; Bucci EM; Lopiano L; Fasano M
IUBMB Life; 2010 Sep; 62(9):688-92. PubMed ID: 20836127
[TBL] [Abstract][Full Text] [Related]
17. DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease.
Lin X; Cook TJ; Zabetian CP; Leverenz JB; Peskind ER; Hu SC; Cain KC; Pan C; Edgar JS; Goodlett DR; Racette BA; Checkoway H; Montine TJ; Shi M; Zhang J
Sci Rep; 2012; 2():954. PubMed ID: 23233873
[TBL] [Abstract][Full Text] [Related]
18. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
[TBL] [Abstract][Full Text] [Related]
19. Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1.
Madian AG; Hindupur J; Hulleman JD; Diaz-Maldonado N; Mishra VR; Guigard E; Kay CM; Rochet JC; Regnier FE
Mol Cell Proteomics; 2012 Feb; 11(2):M111.010892. PubMed ID: 22104028
[TBL] [Abstract][Full Text] [Related]
20. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.
Kahle PJ; Waak J; Gasser T
Free Radic Biol Med; 2009 Nov; 47(10):1354-61. PubMed ID: 19686841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
